424 related articles for article (PubMed ID: 26523264)
41. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
Zhao K; Liu S; Chen Y; Yao Y; Zhou M; Yuan Y; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Zhao H; Lu M; Wu C; Chen X
Emerg Microbes Infect; 2018 Nov; 7(1):186. PubMed ID: 30459339
[TBL] [Abstract][Full Text] [Related]
42. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
[TBL] [Abstract][Full Text] [Related]
43. Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.
Shimura S; Watashi K; Fukano K; Peel M; Sluder A; Kawai F; Iwamoto M; Tsukuda S; Takeuchi JS; Miyake T; Sugiyama M; Ogasawara Y; Park SY; Tanaka Y; Kusuhara H; Mizokami M; Sureau C; Wakita T
J Hepatol; 2017 Apr; 66(4):685-692. PubMed ID: 27890789
[TBL] [Abstract][Full Text] [Related]
44. Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells.
König A; Glebe D
Methods Mol Biol; 2017; 1540():27-36. PubMed ID: 27975305
[TBL] [Abstract][Full Text] [Related]
45. Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicities and Species Specificities of Hepadnaviruses in Primates, Rodents, and Bats.
Jacquet S; Pons JB; De Bernardo A; Ngoubangoye B; Cosset FL; Régis C; Etienne L; Pontier D
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541833
[TBL] [Abstract][Full Text] [Related]
46. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.
Lempp FA; Mutz P; Lipps C; Wirth D; Bartenschlager R; Urban S
J Hepatol; 2016 Mar; 64(3):556-64. PubMed ID: 26576481
[TBL] [Abstract][Full Text] [Related]
47. NTCP-Reconstituted In Vitro HBV Infection System.
Sun Y; Qi Y; Peng B; Li W
Methods Mol Biol; 2017; 1540():1-14. PubMed ID: 27975303
[TBL] [Abstract][Full Text] [Related]
48. Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP.
Huang H; Huang HC; Chiou WC; Lin LC; Chen JC; Liu HK; Lai YH; Huang C
Antiviral Res; 2021 Nov; 195():105184. PubMed ID: 34627935
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
Ni Y; Urban S
Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.
Lempp FA; Qu B; Wang YX; Urban S
J Virol; 2016 May; 90(9):4827-4831. PubMed ID: 26865711
[TBL] [Abstract][Full Text] [Related]
51. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes.
Yan R; Zhang Y; Cai D; Liu Y; Cuconati A; Guo H
PLoS One; 2015; 10(6):e0129889. PubMed ID: 26070202
[TBL] [Abstract][Full Text] [Related]
52. The hepatitis B virus receptor.
Li W
Annu Rev Cell Dev Biol; 2015; 31():125-47. PubMed ID: 26436705
[TBL] [Abstract][Full Text] [Related]
53. Interactions of Na
Zakrzewicz D; Geyer J
Biol Chem; 2023 Jun; 404(7):673-690. PubMed ID: 37103224
[TBL] [Abstract][Full Text] [Related]
54. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.
Iwamoto M; Saso W; Nishioka K; Ohashi H; Sugiyama R; Ryo A; Ohki M; Yun JH; Park SY; Ohshima T; Suzuki R; Aizaki H; Muramatsu M; Matano T; Iwami S; Sureau C; Wakita T; Watashi K
J Biol Chem; 2020 Jan; 295(3):800-807. PubMed ID: 31836663
[TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
Iwamoto M; Saso W; Sugiyama R; Ishii K; Ohki M; Nagamori S; Suzuki R; Aizaki H; Ryo A; Yun JH; Park SY; Ohtani N; Muramatsu M; Iwami S; Tanaka Y; Sureau C; Wakita T; Watashi K
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8487-8492. PubMed ID: 30952782
[TBL] [Abstract][Full Text] [Related]
56. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
[TBL] [Abstract][Full Text] [Related]
57. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
Kaneko M; Futamura Y; Tsukuda S; Kondoh Y; Sekine T; Hirano H; Fukano K; Ohashi H; Saso W; Morishita R; Matsunaga S; Kawai F; Ryo A; Park SY; Suzuki R; Aizaki H; Ohtani N; Sureau C; Wakita T; Osada H; Watashi K
Sci Rep; 2018 Feb; 8(1):2769. PubMed ID: 29426822
[TBL] [Abstract][Full Text] [Related]
58. Initiation of duck hepatitis B virus infection requires cleavage by a furin-like protease.
Tong Y; Tong S; Zhao X; Wang J; Jun J; Park J; Wands J; Li J
J Virol; 2010 May; 84(9):4569-78. PubMed ID: 20181690
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes.
Wang L; Wang C; Wang X; Cao Y; Guo X; Ye Z
Microbiol Spectr; 2024 Mar; 12(3):e0136523. PubMed ID: 38315030
[TBL] [Abstract][Full Text] [Related]
60. Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.
Verrier ER; Colpitts CC; Bach C; Heydmann L; Zona L; Xiao F; Thumann C; Crouchet E; Gaudin R; Sureau C; Cosset FL; McKeating JA; Pessaux P; Hoshida Y; Schuster C; Zeisel MB; Baumert TF
Cell Rep; 2016 Oct; 17(5):1357-1368. PubMed ID: 27783949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
